Abstract:BACKGROUND:At present, studies on MircoRNA-22-3p (miR-22-3p) in lung adenocarcinoma use a single method, lack multi-center validation and multi-method validation, and there is no big data concept to predict and validate target genes.OBJECTIVE:To investigate the expression, potential targets and clinicopathological significance of miR-22-3p in lung adenocarcinoma (LUAD) tissues.METHODS:LUAD formalin-fixed paraffin-embedded (FFPE) tumors and adjacent normal lung tissues were collected for real-time quantitative polymerase chain reaction (RT-qPCR). Collect miR-22-3p in LUAD and non-cancer lung tissue from high-throughput datasets, standardized mean difference (SMD) and area under the curve (AUC) of the comprehensive receiver operating curve (summary receiver operating characteristic cure, sROC curve) were calculated. Cell function experiments on A549 cells transfected with LV-hsa-miR-22-3p. Target genes were predicted by the miRwalk2.0 website and the resulting target genes were subjected to Gene Ontology (GO) pathway enrichment analysis and constructed to protein-protein interaction network. Finally, the protein expression level of the key gene TP53 was validated by searching The Human Protein Atlas (THPA) database to incorporate TP53 immunohistochemical results in LUAD.RESULTS:RT-qPCR result from 41 pairs of LUAD and adjacent lung tissues showed that miR-22-3p was downregulated in LUAD (AUC = 0.6597, p= 0.0128). Globally, a total of 838 LUADs and 494 non-cancerous lung tissues were included, and were finally combined into 14 platforms. Compared with noncancerous tissue, miR-22-3p expression level was significantly reduced in LUAD tissue (SMD =-0.32, AUC = 0.72l); cell function experiments showed that miR-22-3p has inhibitory effects on cell proliferation, migration and invasion, and has promotion effect on apoptosis. Moreover, target genes prediction, GO pathway enrichment analysis and PPI network exhibited TP53 as a key gene of target gene of miR-22-3p; at last, a total of 114 high-throughput datasets were included, including 3897 LUADs and 2993 non-cancerous lung tissues, and were finally combined into 37 platforms. Compared with noncancerous tissue, TP53 expression level was significantly increased in LUAD (SMD = 0.39, p< 0.01) and it was verified by the protein expression data from THPA.CONCLUSION:Overexpression of miR-22-3p may inhibit LUAD cell proliferation, migration and invasion through TP53, and promote cell apoptosis.

miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3

Mir-150 Promotes the Proliferation and Migration of Lung Cancer Cells by Targeting SRC Kinase Signalling Inhibitor 1.

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

Long Non-Coding RNA UCA1 Promotes Lung Cancer Cell Proliferation and Migration Via Microrna-193A/hmgb1 Axis.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48

miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis

Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer

Effects of miR-210 on Mex3 B protein on migration and proliferation of lung cancer cells

MiR-937-3p Promotes Metastasis and Angiogenesis and is Activated by MYC in Lung Adenocarcinoma

MicroRNA-147b Promotes Lung Adenocarcinoma Cell Aggressiveness Through Negatively Regulating Microfibril-Associated Glycoprotein 4 (MFAP4) and Affects Prognosis of Lung Adenocarcinoma Patients.

Mir-517a-3p Accelerates Lung Cancer Cell Proliferation and Invasion Through Inhibiting Foxj3 Expression

MiR-21 and MiR-155 Promote Non-Small Cell Lung Cancer Progression by Downregulating SOCS1, SOCS6, and PTEN

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

MicroRNA-32-5p Inhibits Epithelial-Mesenchymal Transition and Metastasis in Lung Adenocarcinoma by Targeting SMAD Family 3.

Long Non-Coding RNA SOX21-AS1 Modulates Lung Cancer Progress Upon Microrna Mir-24-3p/pim2 Axis.

MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway

The Clinical Significance and Mechanism of Microrna-22-3p Targeting TP53 in Lung Adenocarcinoma.

USF1 Transcriptionally Regulates UGT1A3 and Promotes Lung Adenocarcinoma Progression by Regulating Neurotrophin Signaling Pathway

Mir-21-5p Promotes Lung Adenocarcinoma Progression Partially Through Targeting SET/TAF-Iα.

Mir-212-5p Exerts Tumor Promoter Function by Regulating the Id3/PI3K/Akt Axis in Lung Adenocarcinoma Cells.